Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota.
about
Recent Updates on the Treatment of ConstipationClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic targetEnrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndromeStimulation of Mucin, Mucus, and Viscosity during Lubiprostone in Patients with Chronic Constipation may Potentially Lead to Increase of Lubrication.Lubiprostone in constipation: clinical evidence and place in therapy.Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.Cystic fibrosis: An update for clinicians. Part 1: Nutrition and gastrointestinal complications.New Options in Constipation Management.New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.Swimming through the gut: implications of fluid transport on the microbiome.Bacterial Dissemination to the Brain in Sepsis.Preservation of three-dimensional spatial structure in the gut microbiome.An insight into intestinal mucosal microbiota disruption after stroke.Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease.
P2860
Q26820242-2420952D-BC1D-4D09-A94C-B274D3BE32C3Q28066092-144A288E-10EF-49E9-82B3-106B166D4E29Q28821251-87982C44-42DC-4FF5-8F6F-5295E3FDC2AAQ34760189-DB4145AB-83FB-4D0E-A7E5-FD23C72A5E3FQ35091370-6644E2AA-DF06-4F09-B8CB-32433DD49A4DQ35530569-4098C562-2E78-4AA8-980E-00EEABB7CAD9Q38175457-04DE2F02-29DA-4A56-BD42-9E874DF61455Q38317967-17E9D2E9-50E3-4CF5-95ED-A5E64AD8A444Q38602701-FA1371B7-599F-429C-90F0-3F36FB77536BQ42695148-33518A65-3715-41CD-9004-C0A0772B2536Q42714401-D59D0065-E864-4477-8692-12A170E95566Q46242978-7BF40203-CED5-427B-9855-8C7491210D22Q46254075-4D8431DE-88A8-4613-B15F-6AEB8CBA50FCQ48251322-22B1B566-6741-45AB-AB16-A726411504A5Q54508595-34DF9E8E-D258-49F6-90B5-252D771C15B7
P2860
Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Lubiprostone decreases mouse c ...... alters intestinal microbiota.
@en
Lubiprostone decreases mouse c ...... alters intestinal microbiota.
@nl
type
label
Lubiprostone decreases mouse c ...... alters intestinal microbiota.
@en
Lubiprostone decreases mouse c ...... alters intestinal microbiota.
@nl
prefLabel
Lubiprostone decreases mouse c ...... alters intestinal microbiota.
@en
Lubiprostone decreases mouse c ...... alters intestinal microbiota.
@nl
P2093
P2860
P1476
Lubiprostone decreases mouse c ...... alters intestinal microbiota.
@en
P2093
Erika C Claud
Eugene B Chang
Mark W Musch
Yunwei Wang
P2860
P2888
P304
P356
10.1007/S10620-012-2509-5
P577
2013-01-18T00:00:00Z